1.Frentz, D, Boucher, CA and van de Vijver, DA (2012) Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world. AIDS Reviews 14(1), 17–27.
2.Ma, Y, et al. (2015) Analysis on HIV-1 genetics and threshold of drug resistance in Dehong prefecture of Yunnan province in 2013. Zhonghua liu xing bing xue za zhi=Zhonghua liuxingbingxue zazhi 36(6), 584–588.
3.Shao, YM, Li, JY and Ly, K (2010) The Strategy and Methodology for HIV During Resistance Surveillance and Detection. People's Medical Publishing House, 21.
4.Han, XX, et al. (2005) Efficacy of anti-HIV treatment and drug-resistance mutations in some parts of China. Zhonghua yi xue za zhi 85(11), 760–764.
5.Duong, YT, et al. (2012) Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS ONE 7(3), e33328.10.1371/journal.pone.0033328
6.Zhao, K, et al. (2014) Genotypes and transmitted drug resistance among treatment-naive HIV-1-infected patients in a northwestern province, China: trends from 2003 to 2013. PLoS ONE 9(10), e109821.10.1371/journal.pone.0109821
7.Sui, H, et al. (2014) Different frequencies of drug resistance mutations among HIV-1 subtypes circulating in China: a comprehensive study. PLoS ONE 9(3), e91803.10.1371/journal.pone.0091803
8.Hattori, J, et al. (2016) Japanese drug resistance HIV-1 surveillance network. Characteristics of transmitted drug-resistant HIV-1 in recently infected treatment-naive patients in Japan. Jaids-Journal of Acquired Immune Deficiency Syndrome 71(4), 367–373.10.1097/QAI.0000000000000861
9.Parczewski, M, et al. (2015) Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype. Journal of Antimicrobial Chemotherapy 70(1), 233–242.10.1093/jac/dku372
10.Descamps, D, et al. (2010) ANRS AC11 Resistance Study Group. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France. Journal of Antimicrobial Chemotherapy 65(12), 2620–2627.10.1093/jac/dkq380
11.Chehadeh, W, et al. (2015) Phylogenetic analysis of HIV-1 subtypes and drug resistance profile among treatment-naïve people in Kuwait. Journal of Medical Virology 87(9), 1521–1526.10.1002/jmv.24212
12.Ye, JR, et al. (2009) Prevalence of drug resistance mutations among new confirmed HIV-1 infected patient in Beijing during 2006. Chinese Journal of Microbiology and Immunology 10(29), 886–889.
13.Ye, JR, et al. (2011) Genotypic resistance mutations to antiretroviral drugs in newly confirmed human immunodeficiency virus infectors in Beijing. Zhonghua yi xue za zhi 91(21), 1453–1456.